Emtricitabine/Rilpivirine/Tenofovir disoproxil vs Oseltamivir phosphate
Oseltamivir phosphate was dispensed 336.0× as often as Emtricitabine/Rilpivirine/Tenofovir disoproxil in March 2026 — 336 items versus 1 in England.
Emtricitabine/Rilpivirine/Tenofovir disoproxil · March 2026
NHSBSA Prescription Cost Analysis
Oseltamivir phosphate · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Emtricitabine/Rilpivirine/Tenofovir disoproxil versus Oseltamivir phosphate: national items dispensed by month
▬ Emtricitabine/Rilpivirine/Tenofovir disoproxil · ╌ Oseltamivir phosphate
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Emtricitabine/Rilpivirine/Tenofovir disoproxil | Oseltamivir phosphate |
|---|---|---|
| Items, March 2026 | 1 | 336 |
| Items, last 12 months | 3 | 37,292 |
| Net ingredient cost, March 2026 | £1,052 | £5,074 |
See the full profile for Emtricitabine/Rilpivirine/Tenofovir disoproxil or Oseltamivir phosphate.